v3.26.1
Consolidated Statement of Changes in Shareholders Equity (Deficit) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 79,039 $ 2,954,764 $ (3,001,934) $ 31,869
Balance (in Shares) at Dec. 31, 2023 7,903,850      
Net loss (1,389,990) (1,389,990)
Balance at Dec. 31, 2024 $ 79,039 2,954,764 (4,391,924) (1,358,121)
Balance (in Shares) at Dec. 31, 2024   7,903,850      
Stock-based compensation - stock options 344,186 344,186
Stock-based compensation – common stock grants $ 10,000 1,690,000 1,700,000
Stock-based compensation – common stock grants (in Shares)   1,000,000      
Conversion of convertible debt - related party $ 2,971 496,251 499,222
Conversion of convertible debt - related party (in Shares)   297,133      
Issuance of Representative Warrants in connection with IPO 139,388 139,388
Issuance of common stock in IPO (net of $1,599,060 in offering costs and warrant liability) $ 33,750 11,595,977 11,629,727
Issuance of common stock in IPO (net of $1,599,060 in offering costs and warrant liability) (in Shares)   3,375,000      
Issuance of Representative Warrants in connection with IPO 161,554 161,554
Issuance of Advisory Warrants in connection with Merger 898,300 898,300
Issuance of preferred stock in Merger $ 74,770   145,259,938 145,334,708
Issuance of preferred stock in Merger (in Shares) 7,477,017        
Net loss (6,001,137) (6,001,137)
Balance at Dec. 31, 2025 $ 74,770 $ 125,760 $ 163,540,358 $ (10,393,061) $ 153,347,827
Balance (in Shares) at Dec. 31, 2025 7,477,017 12,575,983